Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.8.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Outstanding and Exercisable Awards
Information regarding outstanding options, restricted stock awards, and restricted stock units is summarized in the tables below:
Total Outstanding and Exercisable Awards December 31, 2017
 
 
 
 
Awards Outstanding
 
Awards Exercisable
Grant Price Low
 
Grant Price High
 
Quantity
 
Remaining Contractual Life (Years)
 
Exercise Price
 
Quantity
 
Remaining Contractual Life (Years)
 
Exercise Price
$

 
1.09
 
510,402
 
2.26
 
$0.55
 
80,666
 
2.40
 
$1.01
$
1.10

 
1.27
 
525,000
 
1.84
 
$1.17
 
262,500
 
1.84
 
$1.17
$
1.28

 
1.56
 
546,000
 
1.35
 
$1.37
 
439,500
 
1.36
 
$1.37
$
1.57

 
2.8
 
305,000
 
0.18
 
$1.75
 
305,000
 
0.18
 
$1.75
$
2.81

 
4.03
 
266,000
 
1.97
 
$3.89
 
239,600
 
1.93
 
$3.88
 
 
 
 
2,152,402
 
1.60
 
$1.49
 
1,327,266
 
1.35
 
$1.85
 
Total Outstanding and Exercisable Awards December 31, 2016
Strike Price
 
Outstanding Options (1 share/option)
 
Average Remaining Life (Years)
 
Exercisable Shares
 
Weighted Average Exercise Price
$
1.01

 
303,500
 
3.40
 

 
$
1.01

$
1.17

 
525,000
 
2.84
 

 
$
1.17

$
1.37

 
644,000
 
2.34
 
419,000

 
$
1.37

$
1.75

 
320,000
 
1.18
 
255,000

 
$
1.75

$
3.85

 
200,000
 
2.85
 
200,000

 
$
3.85

$
3.95

 
100,000
 
3.10
 
100,000

 
$
3.95

$
4.03

 
72,500
 
3.30
 
29,000

 
$
4.03

 
 
2,165,000
 
 
 
1,003,000

 
 
Schedule of Stock Option Activity
Information regarding stock options for the year ended December 31, 2017 is summarized in the tables below:
 
 
Number of Awards
 
Weighted Average Exercise Price
 
Weighted Average Fair Value
 
Weighted Average Remaining Contractual Life (Years)
 
Aggregate Intrinsic Value
Outstanding, beginning of period
 
2,023,500

 
$
1.66


$
1.23

 

 
$
228,180

Exercised/Released
 
(86,333
)
 
$
1.29


$
1.41

 

 
$
42,532

Cancelled/Forfeited
 
(16,500
)
 
$
1.62


$
1.38

 

 
$
2,348

Outstanding, end of period
 
1,920,667

 
$
1.67


$
1.22

 
1.53
 
$
999,487

Vested and exercisable, end of the period
 
1,327,266

 
$
1.85


$
1.39

 
1.35
 
$
563,856

Vested and expected to vest, end of the period
 
1,920,667

 
$
1.67


$
1.22

 
1.53
 
$
999,487


 
 
Number of Awards
 
Weighted Average Exercise Price
 
Weighted Average Grant Date Fair Value
 
Weighted Average Remaining Amortization Period (Years)
Unvested Outstanding, beginning of period
 
1,145,500
 
$
1.30

 
$
0.87

 

Cancelled/Forfeited
 
(5,267)
 
$
1.42

 
$
1.06

 

Vested, outstanding shares
 
(546,832)
 
$
1.32

 
$
0.90

 

Unvested Outstanding, end of period
 
593,401
 
$
1.28

 
$
0.84

 
0.97
Schedule of Restricted Stock Activity
Information regarding restricted stock awards for the year ended December 31, 2017 is summarized in the tables below:


Number of Awards

Weighted Average Exercise Price

Weighted Average Fair Value

Weighted Average Remaining Contractual Life (Years)
Outstanding, beginning of period

73,002


$


$
4.02



Exercised/Released

(24,334
)

$


$
4.02



Outstanding, end of period

48,668


$


$
4.02


2.33
Vested and exercisable, end of the period








Vested and expected to vest, end of the period

48,668


$


$
4.02


2.33

 
 
Number of Awards
 
Weighted Average Exercise Price
 
Weighted Average Grant Date Fair Value
 
Weighted Average Remaining Amortization Period (Years)
Unvested Outstanding, beginning of period
 
73,002
 
$

 
$
4.02

 

Vested, outstanding shares
 
(24,334)
 
$

 
$
4.02

 

Unvested Outstanding, end of period
 
48,668
 
$

 
$
4.02

 
1.33


Information regarding restricted stock units for the year ended December 31, 2017 is summarized in the tables below:
 
 
Number of Awards
 
Weighted Average Exercise Price
 
Weighted Average Fair Value
 
Weighted Average Remaining Contractual Life (Years)
Outstanding, beginning of period
 
281,244

 
$

 
$
1.35

 

Granted
 
162,839

 
$

 
$
1.87

 

Exercised/Released
 
(261,016
)
 
$

 
$
1.36

 

Outstanding, end of period
 
183,067

 
$

 
$
1.80

 
2.04
Vested and exercisable, end of the period
 

 

 

 

Vested and expected to vest, end of the period
 
160,815

 
$

 
$
1.79

 
2.01

 
 
Number of Awards
 
Weighted Average Exercise Price
 
Weighted Average Grant Date Fair Value
 
Weighted Average Remaining Amortization Period (Years)
Unvested Outstanding, beginning of period
 
206,533
 
$

 
$
1.44

 

Granted
 
162,839
 
$

 
$
1.87

 

Vested, outstanding shares
 
(186,305)
 
$

 
$
1.46

 

Unvested Outstanding, end of period
 
183,067
 
$

 
$
1.80

 
1.40